Biological exacerbation clusters demonstrate asthma and COPD overlap with distinct mediator and microbiome profiles

Biological exacerbation clusters demonstrate asthma and COPD overlap with distinct mediator and microbiome profiles

<h4>Background</h4> <p>Exacerbations of asthma and chronic obstructive pulmonary disease (COPD) are heterogeneous.</p> <h4>Objective</h4> <p>We sought to investigate the sputum cellular, mediator, and microbiome profiles of both asthma and COPD exacerbation...

書誌詳細
主要な著者:	Ghebre, M, Pang, P, Diver, S, Desai, D, Bafadhel, M, Haldar, K, Kebadze, T, Cohen, S, Newbold, P, Rapley, L, Woods, J, Rugman, P, Pavord, I, Johnston, S, Barer, M, May, R, Brightling, C
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2018

類似資料

Sputum microbiomic clustering in asthma and COPD reveals a Haemophilus‐predominant subgroup
著者:: Diver, S, 等
出版事項: (2019)

Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics
著者:: Haldar, K, 等
出版事項: (2017)

Inhaled glucocorticoids and COPD exacerbations.
著者:: Brightling, C, 等
出版事項: (2015)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
著者:: Barker, B, 等
出版事項: (2015)

Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease.
著者:: Ghebre, M, 等
出版事項: (2015)

Lung microbiome dynamics in COPD exacerbations
著者:: Wang, Z, 等
出版事項: (2016)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
著者:: Bafadhel M, 等
出版事項: (2015-06-01)

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
著者:: Bafadhel, M, 等
出版事項: (2011)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
著者:: Bafadhel, M, 等
出版事項: (2014)

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
著者:: Bafadhel, M, 等
出版事項: (2009)

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
著者:: Bafadhel, M, 等
出版事項: (2011)

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.
著者:: Thulborn, S, 等
出版事項: (2017)

Aspergillus fumigatus during stable state and exacerbations of COPD.
著者:: Bafadhel, M, 等
出版事項: (2014)

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD
著者:: Thulborn SJ, 等
出版事項: (2017-04-01)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
著者:: Bafadhel, M, 等
出版事項: (2016)

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
著者:: Bafadhel, M, 等
出版事項: (2012)

Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD.
著者:: Doe, C, 等
出版事項: (2010)

Benralizumab for the prevention of COPD exacerbations
著者:: Criner, G, 等
出版事項: (2019)

Late breaking abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes
著者:: Ramsheh, M, 等
出版事項: (2018)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
著者:: Shrimanker, R, 等
出版事項: (2017)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
著者:: Eltboli, O, 等
出版事項: (2014)

Is it time to give up on "self-management" of COPD exacerbations?
著者:: Ramakrishnan, S, 等
出版事項: (2020)

Exacerbations of COPD
著者:: Pavord ID, 等
出版事項: (2016-02-01)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
著者:: Russell, R, 等
出版事項: (2019)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
著者:: Russell REK, 等
出版事項: (2019-05-01)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.
著者:: Siva, R, 等
出版事項: (2014)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
著者:: Siva R, 等
出版事項: (2014-02-01)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
著者:: Barker, R, 等
出版事項: (2017)

COPD exacerbation phenotypes: The next frontier
著者:: Moran, A, 等
出版事項: (2019)

COPD exacerbations: transforming outcomes through research
著者:: Hurst, JR, 等
出版事項: (2018)

Inhaled corticosteroids in COPD.
著者:: Brightling, C, 等
出版事項: (1999)

Characterising non-eosinophilic COPD
著者:: Hambleton, K, 等
出版事項: (2015)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
著者:: Bafadhel, M, 等
出版事項: (2018)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
著者:: Siva, R, 等
出版事項: (2007)

Eosinophils in COPD: just another biomarker?
著者:: Bafadhel, M, 等
出版事項: (2017)

The role of CT scanning in multidimensional phenotyping of COPD.
著者:: Bafadhel, M, 等
出版事項: (2011)

Lung microbiology and exacerbations in COPD
著者:: Beasley V, 等
出版事項: (2012-08-01)

Sputum Moraxella catarrhalis strains exhibit diversity within and between COPD subjects
著者:: George LM, 等
出版事項: (2018-11-01)

Blood eosinophil count and exacerbation risk in patients with COPD.
著者:: Kerkhof, M, 等
出版事項: (2017)

Building toolkits for COPD exacerbations: lessons from the past and present
著者:: Sapey, E, 等
出版事項: (2019)